Cadaveric bone marrow and spleen cells for transplantation

被引:20
作者
Söderdahl, G
Tammik, C
Remberger, M
Ringdén, O
机构
[1] Huddinge Hosp, Dept Clin Immunol, S-14186 Huddinge, Sweden
[2] Huddinge Hosp, Dept Transplantat Surg, S-14186 Huddinge, Sweden
关键词
bone marrow; spleen cells; transplantation; cadaveric; hematopoietic stem cells;
D O I
10.1038/sj.bmt.1701039
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cadaveric bone marrow was harvested from 20 brain-dead donors to determine optimal conditions for procurement for transplantation. The number of nucleated cells obtained from 1 ml of bone marrow was significantly higher in vertebrae (87 +/- 20 x 10(6), mean +/- s.e.m.) than in the sternum (10.2 +/- 3.8 x 10(6)) or ribs (4.9 +/- 2.0 x 10(6)), Viability of cells was not significantly affected by storage temperature (4 degrees C or 20 degrees C) or duration of storage (6-72 h), In addition to bone marrow, spleen cells were harvested from three cadaveric donors, The mean yield from 1 g of spleen tissue was 4.4 x 10(6) nucleated cells, Using magnetic beads, we removed 96% of T lymphocytes without affecting the total yield of stem cells from cadaveric bone marrow, Using CD34-positive cell selection, we obtained a 99.6% T cell depletion efficiency, but with a loss of 60% of CD34-positive cells, Using optimized techniques, we obtained an estimated mean yield of 5.5 x 10(10) mononuclear cells from the whole thoracic and lumbar vertebral column, With a mean fraction of CD34-positive cells of 2.1 +/- 0.3%, recovery and purity were not affected by site of sample, temperature or donor age, In contrast, the CD34-positive fraction in spleen preparations was 0.41 +/- 0.06%. When analyzing the number of colony-forming units (CFU-G<, BFU-E and CFU-GEMM), we found no significant differences between cadaveric bone marrow and bone marrow aspirates from living donors, However, cells harvested from the spleen gave significantly fewer CFUs than did bone marrow from living donors, We conclude that bone marrow from cadaveric donors can be harvested and procured with a high degree of viability and good function, With an appropriate technique of harvesting and procurement, it seems feasible to recover enough stem cells for transplantation.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 24 条
[1]   LONG-TERM RESULTS OF A CONTROLLED PROSPECTIVE-STUDY WITH TRANSFUSION OF DONOR-SPECIFIC BONE-MARROW IN 57 CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].
BARBER, WH ;
MANKIN, JA ;
LASKOW, DA ;
DEIERHOI, MH ;
JULIAN, BA ;
CURTIS, JJ ;
DIETHELM, AG .
TRANSPLANTATION, 1991, 51 (01) :70-75
[2]  
CARIDIS DT, 1973, TRANSPLANT P, V5, P671
[3]  
DOWNIE TR, 1995, BONE MARROW TRANSPL, V15, P499
[4]  
EK S, 1993, BONE MARROW TRANSPL, V11, P395
[5]   BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION [J].
FONTES, P ;
RAO, AS ;
DEMETRIS, AJ ;
ZEEVI, A ;
TRUCCO, M ;
CARROLL, P ;
RYBKA, W ;
RUDERT, WA ;
RICORDI, C ;
DODSON, F ;
SHAPIRO, R ;
TZAKIS, A ;
TODO, S ;
ABUELMAGD, K ;
JORDAN, M ;
FUNG, JJ ;
STARZL, TE .
LANCET, 1994, 344 (8916) :151-155
[6]  
LOKEN MR, 1990, FLOW CYTOMETRY SORTI, P341
[7]   ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA USING SIBLING AND VOLUNTEER UNRELATED DONORS - A COMPARISON OF COMPLICATIONS IN THE 1ST 2 YEARS [J].
MARKS, DI ;
CULLIS, JO ;
WARD, KN ;
LACEY, S ;
SZYDLO, R ;
HUGHES, TP ;
SCHWARER, AP ;
LUTZ, E ;
BARRETT, AJ ;
HOWS, JM ;
BATCHELOR, JR ;
GOLDMAN, JM .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) :207-214
[8]  
MONACO AP, 1970, TRANSPLANT P, V2, P489
[9]   CARDIAC ALLOGRAFT SURVIVAL ACROSS MAJOR HISTOCOMPATIBILITY COMPLEX BARRIERS IN THE RHESUS-MONKEY FOLLOWING LYMPHOCYTE-T DEPLETED AUTOLOGOUS MARROW TRANSPLANTATION .2. PROLONGED ALLOGRAFT SURVIVAL WITH EXTENSIVE MARROW T-CELL DEPLETION [J].
MOSES, RD ;
ORR, KS ;
BACHER, JD ;
SACHS, DH ;
CLARK, RE ;
GRESS, RE .
TRANSPLANTATION, 1989, 47 (03) :435-444
[10]  
MUGISHIMA H, 1985, BLOOD, V65, P392